Rituximab reduces the number of peripheral blood B-cells in vitro mainly by effector cell-mediated mechanisms. [electronic resource]
Producer: 20040106Description: 918-25 p. digitalISSN:- 0390-6078
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Murine-Derived
- B-Lymphocytes -- cytology
- CD3 Complex -- metabolism
- CD56 Antigen -- metabolism
- Cell Count
- Cell Division -- drug effects
- Cell Line, Tumor
- Cells, Cultured
- Humans
- Leukemia, B-Cell -- pathology
- Lipopolysaccharide Receptors -- metabolism
- Rituximab
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.